Maryjane Lacoste joined The Bill and Melinda Gates Foundation in May 2014, working with the Family Planning Team as the Senior Program Officer for Family Planning Service Delivery and Quality. As such, she led the implementation of the Implant Access Program and currently leads and manages the DMPA-SC introduction/scale portfolio, ensuring that the strategy focuses on expanding access to method choice and strengthens quality of care including counseling, interpersonal communications, clinical training, service delivery and performance monitoring. She also oversees the family planning portfolio in Indonesia and guides on postpartum and postabortion FP strategies. Prior to joining the Foundation, Maryjane worked with Jhpiego for over 20 years, spending the last 15 years in the field as country/regional director in Tanzania, Indonesia and Malawi. She has worked with Ministries of Health, donors and other stakeholders to develop and manage implementation of large reproductive health, maternal, newborn and child health and HIV projects in many countries in sub-Saharan Africa, as well as in Indonesia. Maryjane holds a Master of Arts degree from University of Maryland and a Bachelor of Arts degree from Loyola University.
Join industry leaders in discussion on the standardisation of vein-to-vein processes to ensure that digital technologies stay in line with the clinical science that is driving the progression of the field.
Speakers:
Steven Feldman - Stanford University
Frank Thielman - Takeda
Mark Benmoise - Skills Alliance
Seshu Tyagarajan - Novartis Pharmaceuticals Corporation
Key questions addressed:
To review what the impact of the latest oncological data shared at ASH will be, Swapnika Ramu, Scientific Editor, Cell Press will be hosting a free-to-attend panel discussion on December 15th, 2020. Tune in to:
